[go: up one dir, main page]

WO2002048360A1 - Genes du recepteur des oestrogenes et leur utilisation - Google Patents

Genes du recepteur des oestrogenes et leur utilisation Download PDF

Info

Publication number
WO2002048360A1
WO2002048360A1 PCT/JP2001/009996 JP0109996W WO0248360A1 WO 2002048360 A1 WO2002048360 A1 WO 2002048360A1 JP 0109996 W JP0109996 W JP 0109996W WO 0248360 A1 WO0248360 A1 WO 0248360A1
Authority
WO
WIPO (PCT)
Prior art keywords
amino acid
acid sequence
estrogen receptor
seq
utilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2001/009996
Other languages
English (en)
French (fr)
Inventor
Kayo Sumida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to US10/450,484 priority Critical patent/US7432078B2/en
Publication of WO2002048360A1 publication Critical patent/WO2002048360A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PCT/JP2001/009996 2000-12-14 2001-11-15 Genes du recepteur des oestrogenes et leur utilisation Ceased WO2002048360A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/450,484 US7432078B2 (en) 2000-12-14 2001-11-15 Estrogen receptor genes and utilization thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000379993 2000-12-14
JP2000-379993 2000-12-14

Publications (1)

Publication Number Publication Date
WO2002048360A1 true WO2002048360A1 (fr) 2002-06-20

Family

ID=18848258

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/009996 Ceased WO2002048360A1 (fr) 2000-12-14 2001-11-15 Genes du recepteur des oestrogenes et leur utilisation

Country Status (2)

Country Link
US (1) US7432078B2 (ja)
WO (1) WO2002048360A1 (ja)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011760A1 (en) * 1997-09-04 1999-03-11 The Regents Of The University Of California DIFFERENTIAL LIGAND ACTIVATION OF ESTROGEN RECEPTORS ERα AND ERβ AT AP1 SITES
JP2000201688A (ja) * 1998-11-10 2000-07-25 Sumitomo Chem Co Ltd エストロジェンレセプタ―遺伝子およびその利用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011760A1 (en) * 1997-09-04 1999-03-11 The Regents Of The University Of California DIFFERENTIAL LIGAND ACTIVATION OF ESTROGEN RECEPTORS ERα AND ERβ AT AP1 SITES
JP2000201688A (ja) * 1998-11-10 2000-07-25 Sumitomo Chem Co Ltd エストロジェンレセプタ―遺伝子およびその利用

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDREE KRUST ET AL.: "The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors", THE EMBO JOURNAL, vol. 5, no. 5, 1986, pages 891 - 897, XP001057526 *
ERIN C. JACOBS ET AL.: "Zebra fish estrogen receptor cDNA: Cloning and mRNA expression", J. STEROID BIOCHEM. MOLEC. BIOL., vol. 59, no. 2, 1996, pages 135 - 145, XP002907921 *
MARC VIDAL ET AL.: "Survey and summary: Yeast forward and reverse 'n'-hybrid systems", NUCLEIC ACIDS RESEARCH, vol. 27, no. 4, 1999, pages 919 - 929, XP002907923 *

Also Published As

Publication number Publication date
US20040121355A1 (en) 2004-06-24
US7432078B2 (en) 2008-10-07

Similar Documents

Publication Publication Date Title
CA2289914A1 (en) Igf-1 receptor interacting proteins (iips), genes coding therefor and uses thereof
WO2001079462A3 (en) Nucleic acids encoding polypeptides having haloperoxidase activity
WO2001079463A3 (en) Nucleic acids encoding polypeptides having haloperoxidase activity
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
WO2002044385A1 (en) Gene encoding acetolactic acid synthase gene
WO2003020932A1 (en) Novel secretory proteins and dna thereof
WO2003006644A3 (de) Lipase/acyltransferase
WO2001068859A3 (en) Il-17 receptor like molecules and uses thereof
WO2001068705A3 (en) Il-17 receptor like molecules and uses thereof
NZ527971A (en) Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
CA2281206A1 (en) Geranyl diphosphate synthase genes
WO1996040040A3 (en) Thrombin receptor homolog
CA2361987A1 (en) Goodpasture antigen binding protein
WO2002010336A3 (en) Mutacin i biosynthesis genes and proteins
IL142709A0 (en) Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
EP1757684A3 (en) A 2,6-beta-D-fructan hydrolase enzyme and processes for using the enzyme
WO2000020450A3 (en) Calcium channel alpha-2/delta gene
WO2002048360A1 (fr) Genes du recepteur des oestrogenes et leur utilisation
WO2002038607A3 (en) A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
WO2001049714A3 (en) Nope polypeptides, encoding nucleic acids and methods of use
CA2311646A1 (en) Tsa305 gene
MXPA04000397A (es) Polipeptidos que tienen actividad catalitica de isomerasa de carotenoides, acidos nucleicos que los codifican y usos de los mismos.
WO2002031146A3 (en) Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
WO2001087932A3 (en) Seven transmembrane proteins and polynucleotides encoding the same
EP1065269A4 (en) GENE CODING FOR HM1.24 AND PROMOTOR THEREOF

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): DE FR GB NL

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10450484

Country of ref document: US

122 Ep: pct application non-entry in european phase